Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
ECHENBERG PAUL S
   2. Issuer Name and Ticker or Trading Symbol
EZ EM INC [EZM] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
717 MAIN STREET		 3. Date of Earliest Transaction (Month/Day/Year)
11/01/2004
(Street)

WESTBURY, NY 115905021		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/01/2004   A(1)   1,000 A $ 0 38,339 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock Option (2) $ 2.3681             05/15/1996 05/14/2005 Common Stock 29,919   29,919 (3) D  
Common Stock Option (2) $ 2.5161             06/03/1996 06/02/2005 Common Stock 995   995 (4) D  
Common Stock Option (2) $ 8.0794             06/01/1997 05/31/2006 Common Stock 967   967 (5) D  
Common Stock Option (2) $ 4.789             05/31/1998 05/30/2007 Common Stock 940   940 (6) D  
Common Stock Option (2) $ 3.8006             05/30/1999 05/29/2008 Common Stock 912   912 (7) D  
Common Stock Option (2) $ 3.2346             05/29/2000 05/28/2009 Common Stock 912   912 (8) D  
Common Stock Option (2) $ 4.2049             06/03/2001 06/02/2010 Common Stock 912   912 (9) D  
Common Stock Option (2) $ 3.3639             06/02/2002 06/01/2011 Common Stock 912   912 (10) D  
Common Stock Option (2) $ 5.8222             06/01/2003 05/31/2012 Common Stock 912   912 (11) D  
Common Stock Option (2) $ 5.434             05/31/2004 05/30/2013 Common Stock 912   912 (12) D  
Common Stock Option (2) $ 12.0971             05/29/2005 05/28/2014 Common Stock 912   912 (13) D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
ECHENBERG PAUL S
717 MAIN STREET
WESTBURY, NY 115905021		   X      

Signatures

 By: Joseph A. Cacchioli, as Attorney-In-Fact   11/03/2004
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Director compensation in the form of a Restricted Stock Grant.
(2) Options granted under E-Z-EM's Directors and Consultants Stock Option Plan.
(3) This option was previously reported as covering 32,781 shares at an exercise price of $3.6606 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $2.3681 per share and the number of shares was reduced to 29,919, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off.
(4) This option was previously reported as covering 1,091 shares at an exercise price of $3.8894 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $2.5161 per share and the number of shares was reduced to 995, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off.
(5) This option was previously reported as covering 1,060 shares at an exercise price of $12.4894 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $8.0794 per share and the number of shares was reduced to 967, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off.
(6) This option was previously reported as covering 1,030 shares at an exercise price of $7.4029 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $4.7890 per share and the number of shares was reduced to 940, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off.
(7) This option was previously reported as covering 1,000 shares at an exercise price of $5.875 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $3.8006 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off.
(8) This option was previously reported as covering 1,000 shares at an exercise price of $5.00 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $3.2346 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off.
(9) This option was previously reported as covering 1,000 shares at an exercise price of $6.50 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $4.2049 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off.
(10) This option was previously reported as covering 1,000 shares at an exercise price of $5.20 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $3.3639 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off.
(11) This option was previously reported as covering 1,000 shares at an exercise price of $9.00 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $5.8222 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off.
(12) This option was previously reported as covering 1,000 shares at an exercise price of $8.40 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $5.4340 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off.
(13) This option was previously reported as covering 1,000 shares at an exercise price of $18.70 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $12.0971 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.